Holen Sie sich die Stockscreener-App
20.26
4.51%
-0.98
Schlusskurs vom Vortag:
$21.24
Offen:
$20.99
24-Stunden-Volumen:
146.93K
Relative Volume:
0.28
Marktkapitalisierung:
$379.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-5.40%
1M Leistung:
+23.37%
6M Leistung:
-9.65%
1J Leistung:
-60.43%
1-Tages-Spanne:
$20.20
$21.49
1-Wochen-Bereich:
$18.60
$21.65
52-Wochen-Spanne:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Firmenname
Tectonic Therapeutic Inc
Sektor
Branche
Telefon
(339) 666-3320
Adresse
490 ARSENAL WAY, WATERTOWN
Vergleichen Sie TECX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
20.26 | 392.67M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.27 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
721.81 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.23 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
902.23 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.61 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-03 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-21 | Eingeleitet | Mizuho | Outperform |
| 2024-11-20 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | TD Cowen | Buy |
| 2023-12-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-05 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Buy |
| 2021-03-09 | Eingeleitet | Barclays | Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-03-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-07-16 | Eingeleitet | Wedbush | Outperform |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
Will Tectonic Therapeutic Inc. stock continue upward momentumProfit Target & Community Consensus Trade Alerts - Newser
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives $82.17 Average Target Price from Brokerages - Defense World
Tectonic Therapeutic to Participate in December Investor Conferences - The Manila Times
Tectonic Therapeutic (NASDAQ: TECX) to join Piper Sandler fireside chat, Evercore investor meetings in December - Stock Titan
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Can Tectonic Therapeutic Inc. stock deliver strong Q4 earnings2025 AllTime Highs & Weekly Setup with High ROI Potential - moha.gov.vn
Its Stock Has Paid Off Big Time For Tectonic Therapeutic Inc - Setenews
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Will Tectonic Therapeutic Inc. stock deliver long term returnsJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Will Tectonic Therapeutic Inc. stock keep outperforming rivalsJuly 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com
Is Tectonic Therapeutic Inc. forming a reversal patternMarket Trend Report & Reliable Intraday Trade Plans - newser.com
What is the fair value of Tectonic Therapeutic Inc. stock nowWeekly Stock Recap & Accurate Buy Signal Alerts - newser.com
Tools to monitor Tectonic Therapeutic Inc. recovery probabilityTrade Exit Report & Weekly Stock Breakout Alerts - newser.com
Is Tectonic Therapeutic Inc. meeting your algorithmic filter criteriaEarnings Risk Summary & Safe Entry Zone Tips - newser.com
How high can Tectonic Therapeutic Inc. stock goJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com
Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point (TECX) - Seeking Alpha
Price action breakdown for Tectonic Therapeutic Inc.Portfolio Risk Summary & Verified Short-Term Trading Plans - newser.com
Tectonic Therapeutic Inc Stock Analysis and ForecastStock Market Trends & These 3 Stocks Could Change Your Portfolio - earlytimes.in
What data driven models say about Tectonic Therapeutic Inc.’s futureShare Buyback & Daily Volume Surge Trade Alerts - newser.com
What recovery options are there for Tectonic Therapeutic Inc.2025 Trade Ideas & Weekly Setup with ROI Potential - newser.com
Will Tectonic Therapeutic Inc. stock outperform value stocks2025 Dividend Review & Free Low Drawdown Momentum Trade Ideas - Fundação Cultural do Pará
How to track smart money flows in Tectonic Therapeutic Inc.July 2025 Sector Moves & Breakout Confirmation Alerts - newser.com
Can Tectonic Therapeutic Inc. stock sustain market leadership2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
What institutional flow reveals about Tectonic Therapeutic Inc.Market Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Can Tectonic Therapeutic Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
It is Poised to be a Bull Market for Tectonic Therapeutic Inc (TECX) - Setenews
Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)
Es liegen keine Finanzdaten für Tectonic Therapeutic Inc (TECX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):